OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness

VC-02 combination product (PEC-Direct) is a clinical-stage regenerative medicine therapy being developed for patients with type 1 diabetes and hypoglycemia unawareness intended to restore homeostatic glycemic control. It is comprised of stem cell-derived pancreatic progenitors (PEC-01) loaded into a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellin, Melena, Daniels, Mark, Foyt, Howard, Keymeulen, Bart, Kieffer, Timothy, Kroon, Evert, Pipeleers, Daniel, Thompson, David, Wang, Richard, Jaiman, Manasi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624949/
http://dx.doi.org/10.1210/jendso/bvac150.727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624949/
http://dx.doi.org/10.1210/jendso/bvac150.727

Ejemplares similares